DE60229044D1 - Magensaftresistente salze von ketosäuren und aminosäuren und ihre verwendung zur herstellung von medikamenten - Google Patents

Magensaftresistente salze von ketosäuren und aminosäuren und ihre verwendung zur herstellung von medikamenten

Info

Publication number
DE60229044D1
DE60229044D1 DE60229044T DE60229044T DE60229044D1 DE 60229044 D1 DE60229044 D1 DE 60229044D1 DE 60229044 T DE60229044 T DE 60229044T DE 60229044 T DE60229044 T DE 60229044T DE 60229044 D1 DE60229044 D1 DE 60229044D1
Authority
DE
Germany
Prior art keywords
acids
ketosic
medicaments
manufacture
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60229044T
Other languages
English (en)
Inventor
Thierry Bouyssou
Serge Biosa
Christian Jeanpetit
Daniel Kilhoffer
Peillet-Feuillet Eliane Le
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiesi Farmaceutici SpA
Original Assignee
Chiesi Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA
Application granted granted Critical
Publication of DE60229044D1 publication Critical patent/DE60229044D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
DE60229044T 2001-03-29 2002-03-27 Magensaftresistente salze von ketosäuren und aminosäuren und ihre verwendung zur herstellung von medikamenten Expired - Fee Related DE60229044D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0104259A FR2822704B1 (fr) 2001-03-29 2001-03-29 Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de medicaments
PCT/FR2002/001061 WO2002078676A2 (fr) 2001-03-29 2002-03-27 Sels de cetoacides et d'acides amines gastroresistants

Publications (1)

Publication Number Publication Date
DE60229044D1 true DE60229044D1 (de) 2008-11-06

Family

ID=8861695

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60229044T Expired - Fee Related DE60229044D1 (de) 2001-03-29 2002-03-27 Magensaftresistente salze von ketosäuren und aminosäuren und ihre verwendung zur herstellung von medikamenten

Country Status (15)

Country Link
US (1) US20040127413A1 (de)
EP (1) EP1372617B1 (de)
AT (1) ATE409027T1 (de)
AU (1) AU2002308031A1 (de)
CA (1) CA2442691A1 (de)
CZ (1) CZ20032488A3 (de)
DE (1) DE60229044D1 (de)
DZ (1) DZ3512A1 (de)
EA (1) EA007010B1 (de)
FR (1) FR2822704B1 (de)
HU (1) HUP0303628A2 (de)
MA (1) MA26009A1 (de)
PL (1) PL365213A1 (de)
TN (1) TNSN03075A1 (de)
WO (1) WO2002078676A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004069236A1 (ja) * 2003-02-06 2004-08-19 Otsuka Pharmaceutical Factory, Inc. 周術期血糖値上昇抑制剤
EP1638546A1 (de) * 2003-07-01 2006-03-29 Essentys AB Verwendung von alpha-ketoglutarsäure zur behandlung von unterernährung oder hohem plasma-blutzucker
PL369552A1 (pl) * 2004-08-12 2006-02-20 Sgp & Sons Ab Preparat farmaceutyczny lub/i żywieniowy lub/i laboratoryjny wzmagający, wspomagający funkcjonowanie komórek nerwowych i układu nerwowego oraz zastosowanie preparatu farmaceutycznego lub/i żywieniowego w procesie ochrony funkcji układu nerwowego oraz zastosowanie preparatu do ochrony wzrostu stymulacji namnażania i zapobiegania apoptozie komórek nerwowych
PL226695B1 (pl) * 2006-07-03 2017-08-31 Danuta Kruszewska Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori
US20100303901A1 (en) * 2007-04-26 2010-12-02 Eyal Shimoni Oral delivery of proteins and peptides
CN104825433A (zh) * 2007-07-03 2015-08-12 达努塔·克鲁谢夫斯卡 α-酮戊二酸的新医药用途
FR2953719A1 (fr) 2009-12-10 2011-06-17 Luc Cynober Nouvelles applications therapeutiques d'un complexe d'alpha-cetoglutarate et d'ornithine
US20150025147A1 (en) * 2012-03-02 2015-01-22 Kyowa Hakko Bio Co., Ltd Enhancer for eating activity and/or gastrointestinal activity
ITBO20120226A1 (it) 2012-04-24 2013-10-25 Alfa Wassermann Spa Composizioni comprendenti ornitina alfa-chetoglutarato, processi per il loro ottenimento e il loro uso.
WO2016003854A1 (en) * 2014-06-30 2016-01-07 The Regents Of The University Of California Ketobutyrate compounds and compositions for treating age-related symptoms and diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441650A (en) * 1965-07-23 1969-04-29 Lab Jacques Logeais Sa Therapy of ammonical intoxications by di-l-ornithine alpha-ketoglutarate
FR2618331B1 (fr) * 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
US4957938A (en) * 1989-06-21 1990-09-18 Abbott Laboratories Nutritional formulation for the treatment of renal disease
US5234696A (en) * 1991-12-27 1993-08-10 Abbott Laboratories Method of producing tablets, tablets produced thereby, and method of treatment using same
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
US5912014A (en) * 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
FR2775901B1 (fr) * 1998-03-13 2000-07-21 Logeais Labor Jacques Sels de cetoacides et de derives amines, et leur utilisation pour la preparation de medicaments
FR2793688B1 (fr) * 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
US6503506B1 (en) * 2001-08-10 2003-01-07 Millenium Biotechnologies, Inc. Nutrient therapy for immuno-compromised patients

Also Published As

Publication number Publication date
WO2002078676A2 (fr) 2002-10-10
CZ20032488A3 (cs) 2004-10-13
FR2822704B1 (fr) 2005-02-18
FR2822704A1 (fr) 2002-10-04
EP1372617B1 (de) 2008-09-24
WO2002078676A3 (fr) 2003-01-16
AU2002308031A1 (en) 2002-10-15
HUP0303628A2 (hu) 2004-03-01
EA007010B1 (ru) 2006-06-30
ATE409027T1 (de) 2008-10-15
EA200300940A1 (ru) 2004-04-29
TNSN03075A1 (fr) 2005-12-23
PL365213A1 (en) 2004-12-27
MA26009A1 (fr) 2003-12-31
EP1372617A2 (de) 2004-01-02
DZ3512A1 (fr) 2002-10-10
CA2442691A1 (en) 2002-10-10
US20040127413A1 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
DE60238576D1 (de) Zusammensetzung zur Herstellung von Elektroden und Elektroden
DE60335560D1 (de) Zusammensetzungen enthaltend zitronensäure zur behandlung von nagelpilzerkrankungen
ATE350375T1 (de) 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60142473D1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
DE60311272D1 (de) Neue purin- oder pyrrolol(2,3-d)pyrimidin-2-carbonsäurenitrile zur behandlung von mit cysteinproteaseaktivität assoziierten krankheiten
ATE358669T1 (de) Pyrazolderivate zur behandlung von hiv
ATE401309T1 (de) Verwendung von 2-fuoro-3-ketoestern zur herstellung von 3-fuoro-6,7,8,9-tetrahydro-4h- pyrimidoä1,2-aüpyrimidin-4-onen
WO2003039454A3 (en) Beta-secretase inhibitors and methods of use
DE60222644D1 (de) Prozess zur herstellung von transparenten formteilen
ATE273304T1 (de) (s)-4-amino-5-chloro-2-methoxy-n-(1-(1-(2- tetrahydrofuryl-carbonyl)-4-piperidinylmethyl)- - piperidinyl)benzamid zur behandlung von magen- darmbewegungskrankheiten
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
DE60013021D1 (de) Herstellung von S,S und R,S Aminosäuren-Isosteren
ATE279386T1 (de) Retinoide zur behandlung von emphysem
DE60229044D1 (de) Magensaftresistente salze von ketosäuren und aminosäuren und ihre verwendung zur herstellung von medikamenten
ATE546425T1 (de) Herstellung von (r)-2-alkyl-3-phenylpropionsäuren
DE50211532D1 (de) Verfahren zur herstellung von legierungs-ingots
DE60205955D1 (de) Verfahren zur Herstellung von L-Aminosäuren
ATE218335T1 (de) Salze der ketosäuren und amine sowie ihre verwendung zur herstellung von medikamenten
ATA14332001A (de) Walzgerüst zur herstellung von walzband
ATE418552T1 (de) Substituierte amino-furan-2-yl-essigsaure- und amino-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
DE60038057D1 (de) Methode zur photoreduktion von hämoglobin-vesikeln
DE50209948D1 (de) Verwendung von Scopinester Derivaten zur Herstellung von Arzneimitteln
ATE330596T1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
DE60216135D1 (de) Prozess zur herstellung von organischen hydroperoxiden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee